SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCC
- 30 June 2013
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 58 (6), 1157-1164
- https://doi.org/10.1016/j.jhep.2013.01.025
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Systematic -omics analysis of HBV-associated liver diseasesCancer Letters, 2009
- NF-κB signaling, liver disease and hepatoprotective agentsOncogene, 2008
- Introduction to NF-κB: players, pathways, perspectivesOncogene, 2006
- IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical HepatocarcinogenesisCell, 2005
- Shaping the nuclear action of NF-κBNature Reviews Molecular Cell Biology, 2004
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteinsJournal of Virology, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996